{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:20Z","timestamp":1767135260587,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":116,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003456.pub2","type":"reference-entry","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:41:25Z","timestamp":1082713285000},"source":"Crossref","is-referenced-by-count":3,"title":["Drug therapy for chronic idiopathic axonal polyneuropathy"],"prefix":"10.1002","author":[{"given":"Alexander FJE","family":"Vrancken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolette C","family":"Notermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,19]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD003456.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1212\/WNL.38.11.1731","article-title":"Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia","volume":"38","author":"Bradley","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-199510060-00001","article-title":"L-acetylcarnitine in the treatment of patients with peripheral neuropathies: A short term, double-blind clinical study of 426 patients","volume":"10","author":"Grandis","year":"1995","journal-title":"Clinical Drug Investigation"},{"issue":"7637","key":"10.1002\/14651858.CD003456.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD003456.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/WNL.55.7.971","article-title":"Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions","volume":"55","author":"Galer","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain","volume":"24","author":"Ho","year":"2008","journal-title":"The Clinical Journal of Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003456.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pain.2008.07.013","article-title":"Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies","volume":"141","author":"Ho","year":"2009","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpain.2009.08.002","article-title":"Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain","volume":"14","author":"Huge","year":"2010","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB8|cit8","first-page":"714","article-title":"Behandlung von Polyneuropathien. Untersuchungen zur Wirksamkeit von Ginkgo-biloba-Exrakt EGb 761 bei Patienten mit Polyneuropathie","volume":"69","author":"Husstedt","year":"1993","journal-title":"Zeitschrift f\u00fcr Allgemeine Medizin"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3959(89)90134-6","article-title":"Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain","volume":"37","author":"Kishore-Kumar","year":"1989","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000115497","article-title":"An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies","volume":"21","author":"Langohr","year":"1982","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6882-10-22","article-title":"The effect of Neuragen PN on neuropathic pain: a randomized, double blind, placebo controlled clinical trial","volume":"10","author":"Li","year":"2010","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(94)00261-C","article-title":"Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy","volume":"62","author":"Low","year":"1995","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(02)00020-9","article-title":"Morphine responsiveness, efficacy and tolerability in patients with chronic no-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS)","volume":"97","author":"Maier","year":"2002","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0269216303pm815oa","article-title":"Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial","volume":"17","author":"Morley","year":"2003","journal-title":"Palliative Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD003456.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB17|cit17","first-page":"9","article-title":"L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain","volume":"15","author":"Onofrj","year":"1995","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.62.2.285","article-title":"Valproic acid has no effect in polyneuropathy. A randomized, controlled trial","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","article-title":"Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial","volume":"139","author":"Otto","year":"2008","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"Journal of Pain and Symptom Management"},{"issue":"13","key":"10.1002\/14651858.CD003456.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.57.9.1583","article-title":"Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain","volume":"57","author":"Semenchuck","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/cp.1999.v66.103171001","article-title":"The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels","volume":"66","author":"Sindrup","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0304-3959(00)00457-7","article-title":"St. John's wort has no effect on pain in polyneuropathy","volume":"91","author":"Sindrup","year":"2001","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002508-199712000-00009","article-title":"A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics","volume":"13","author":"Vrethem","year":"1997","journal-title":"Clinical Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB28|cit28","first-page":"459","article-title":"Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study","volume":"25","author":"Wallace","year":"2000","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jpai.2002.123650","article-title":"A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain","volume":"3","author":"Wallace","year":"2002","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1085-9489.2004.09311.x","article-title":"Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy","volume":"9","author":"Windebank","year":"2004","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB31|cit31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004573.pub3","article-title":"Vitamin B for treating peripheral neuropathy","author":"Ang","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0404.1989.tb03745.x","article-title":"The yield of sural nerve biopsy in the evaluation of peripheral neuropathies","volume":"79","author":"Argov","year":"1989","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s004010051162","article-title":"Unmyelinated nerve fiber degeneration in chronic inflammatory demyelinating polyneuropathy","volume":"99","author":"Bosboom","year":"2000","journal-title":"Acta Neuropathologica (Berlin)"},{"key":"10.1002\/14651858.CD003456.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archneur.55.7.981","article-title":"Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients","volume":"55","author":"Camerlingo","year":"1998","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003456.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpain.2005.09.004","article-title":"Economic evaluation of oral treatments for neuropathic pain","volume":"7","author":"Cepeda","year":"2006","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB38|cit38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003345.pub2","article-title":"Systemic administration of local anesthetic agents to relieve neuropathic pain","author":"Challapalli","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/brain\/119.4.1091","article-title":"Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients","volume":"119","author":"Chia","year":"1996","journal-title":"Brain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0960-8966(99)00094-2","article-title":"Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy","volume":"10","author":"Deprez","year":"2000","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB41|cit41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007393.pub2","article-title":"Topical capsaicin for chronic neuropathic pain in adults","author":"Derry","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aen107","article-title":"Neuropathic pain: emerging treatments","volume":"101","author":"Dray","year":"2008","journal-title":"British Journal of Anaesthesia"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003456.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD003456.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.410100304","article-title":"Intensive evaluation of referred unclassified neuropathies yields improved diagnosis","volume":"10","author":"Dyck","year":"1981","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.41.6.799","article-title":"The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests","volume":"41","author":"Dyck","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1212\/WNL.42.6.1164","article-title":"The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity","volume":"42","author":"Dyck","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mus.20846","article-title":"Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study","volume":"36","author":"Dyck","year":"2007","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB49|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006146","article-title":"Opioids for neuropathic pain","author":"Eisenberg","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0033-0620(03)80004-X","article-title":"Cigarette smoking and diabetes","volume":"45","author":"Eliasson","year":"2003","journal-title":"Progression in Cardiovascular Disease"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000315037","article-title":"Pain in patients with chronic idiopathic axonal polyneuropathy","volume":"64","author":"Erdmann","year":"2010","journal-title":"European Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB52|cit52","first-page":"36","article-title":"An evidence-based algorithm for the treatment of neuropathic pain","volume":"9","author":"Finnerup","year":"2007","journal-title":"Medscape General Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00401-002-0669-7","article-title":"Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of unknown etiology","volume":"105","author":"Fressinaud","year":"2003","journal-title":"Acta Neuropathologica (Berlin)"},{"key":"10.1002\/14651858.CD003456.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/jnnp.69.4.442","article-title":"Prospective study of the usefulness of sural nerve biopsy","volume":"69","author":"Gabriel","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003456.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1517\/13543784.9.10.2331","article-title":"Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders","volume":"9","author":"Gold","year":"2000","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1179\/016164104225013734","article-title":"Neurorgenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies","volume":"26","author":"Gold","year":"2004","journal-title":"Neurologic Research"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the overall neuropathy limitations scale","volume":"77","author":"Graham","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jnnp.2005.081497","article-title":"Clinimetric properties of a walking scale in peripheral neuropathy","volume":"77","author":"Graham","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.1991.tb04942.x","article-title":"Cryptogenetic polyneuropathies: an out-patient follow-up study","volume":"84","author":"Grahmann","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijo.0803418","article-title":"Prevalence of somatic small fiber neuropathy in obesity","volume":"31","author":"Herman","year":"2007","journal-title":"International Journal of Obesity"},{"issue":"7414","key":"10.1002\/14651858.CD003456.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003456.pub2-BIB63|cit63","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 [updated September 2009] The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB64|cit64","article-title":"Tramadol for neuropathic pain","author":"Hollingshead","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Pt 8","key":"10.1002\/14651858.CD003456.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awh192","article-title":"A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy","volume":"127","author":"Hughes","year":"2004","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB66|cit66","first-page":"69","article-title":"Peripheral neuropathy in chronic respiratory insufficiency","volume":"3","author":"Jann","year":"1998","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/mus.1132","article-title":"Prospective follow-up study of chronic polyneuropathy of undetermined cause","volume":"24","author":"Jann","year":"2001","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003456.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003456.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1085-9489.2004.09105.x","article-title":"The role of growth factors in diabetic peripheral neuropathy","volume":"9","author":"Leinninger","year":"2004","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB70|cit70","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006051","article-title":"Prostaglandin E1 for diabetic neuropathy","author":"Li","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1085-9489.2005.10106.x","article-title":"Cryptogenic polyneuropathy: clinical and neurophysiological findings","volume":"10","author":"Lindh","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD003456.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mus.880170908","article-title":"Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy","volume":"17","author":"Logigian","year":"1994","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB73|cit73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853890008995903","article-title":"Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?","volume":"32","author":"Malik","year":"2000","journal-title":"Annals of Medicine"},{"issue":"15 Supplement 1","key":"10.1002\/14651858.CD003456.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jpain.2005.09.008","article-title":"Ion channel targets and treatment efficacy in neuropathic pain","volume":"7","author":"Markman","year":"2006","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD003456.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.47.5.530","article-title":"Chronic polyneuropathy of undetermined cause","volume":"47","author":"McLeod","year":"1984","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nmd.2005.12.003","article-title":"131st ENMC International workshop: Selection of outcome measures for peripheral neuropathy clinical trials, 10-12 December, Naarden, The Netherlands","volume":"16","author":"Merkies","year":"2006","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB78|cit78","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001447.pub2","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB79|cit79","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005492","article-title":"Alpha-lipoic acid for diabetic peripheral neuropathy","author":"Mirza","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB80|cit80","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007938","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003456.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"M\u00fcller","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"issue":"8","key":"10.1002\/14651858.CD003456.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1468-1331.2008.02197.x","article-title":"Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series","volume":"15","author":"Nebuchennykh","year":"2008","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000117372","article-title":"Postoperative effects and value of sural nerve biopsies: a retrospective study","volume":"30","author":"Neund\u00f6rfer","year":"1990","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jnnp.56.10.1066","article-title":"Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients","volume":"56","author":"Notermans","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","article-title":"Chronic idiopathic axonal polyneuropathy: a five year follow up","volume":"57","author":"Notermans","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3349\/ymj.1990.31.1.1","article-title":"Diagnostic usefulness and limitations of the sural nerve biopsy","volume":"31","author":"Oh","year":"1990","journal-title":"Yonsei Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1602\/neurorx.2.4.650","article-title":"Challenges in the development of novel treatment strategies for neuropathic pain","volume":"2","author":"Ossipov","year":"2005","journal-title":"Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub2-BIB88|cit88","first-page":"389","article-title":"Peripheral neuropathy associated with chronic obstructive pulmonary disease","volume":"12","author":"Poza","year":"1997","journal-title":"Neurolog\u00eda"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB89|cit89","first-page":"147","article-title":"Treatment of peripheral neuropathies with neurotrophic factors: animal models and clinical trials","volume":"159","author":"Pradat","year":"2003","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD003456.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60: II. Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD003456.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9610(05)80968-7","article-title":"Clinical utilization and complications of sural nerve biopsy","volume":"166","author":"Rappaport","year":"1993","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD003456.pub2-BIB92|cit92","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.02 2008"},{"key":"10.1002\/14651858.CD003456.pub2-BIB93|cit93","first-page":"CD005454","article-title":"Antidepressants for neuropathic pain","volume":"Issue 4","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB94|cit94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003908.pub2","article-title":"Rehabilitation interventions for foot drop in neuromuscular disease","author":"Sackley","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"9","key":"10.1002\/14651858.CD003456.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003456.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD003456.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/NRL.0b013e31815a3956","article-title":"Impaired glucose tolerance and neuropathy","volume":"14","author":"Smith","year":"2008","journal-title":"The Neurologist"},{"issue":"1-2","key":"10.1002\/14651858.CD003456.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.06.005","article-title":"Idiopathic neuropathy patients are at high risk for metabolic syndrome","volume":"273","author":"Smith","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003456.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004150050562","article-title":"Quality of life in patients with axonal polyneuropathy","volume":"247","author":"Teunissen","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000008185","article-title":"Relationship between ischemia and neuropathy","volume":"44","author":"Teunissen","year":"2000","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010000193","article-title":"Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy","volume":"100","author":"Teunissen","year":"2000","journal-title":"Acta Neuropathologica (Berlin)"},{"key":"10.1002\/14651858.CD003456.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.72.5.590","article-title":"Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?","volume":"72","author":"Teunissen","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003456.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD003456.pub2-BIB105|cit105","first-page":"129","article-title":"Idiopathic polyneuropathy. A prospective study including gastrointestinal investigation","volume":"37","author":"Vilming","year":"1987","journal-title":"Journal of Oslo City Hospital"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archneur.59.4.533","article-title":"Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people","volume":"59","author":"Vrancken","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003456.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00415-004-0275-9","article-title":"Progressive idiopathic axonal neuropathy: a comparative clinical and histopathological study with vasculitic neuropathy","volume":"251","author":"Vrancken","year":"2004","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB108|cit108","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003904.pub2","article-title":"Exercise for people with peripheral neuropathy","author":"White","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003456.pub2-BIB109|cit109","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008146","article-title":"Interventions for fatigue in peripheral neuropathy","author":"White","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB110|cit110","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB111|cit111","article-title":"Carbamazepine for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003456.pub2-BIB112|cit112","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006044.pub2","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003456.pub2-BIB113|cit113","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.56.5.540","article-title":"Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics","volume":"56","author":"Wolfe","year":"1999","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD003456.pub2-BIB115|cit115","first-page":"S255","article-title":"Treatment of diabetic neuropathy and neuropathic pain: how far have we come?","volume":"31 Suppl 2","author":"Ziegler","year":"2008","journal-title":"Diabetes care"},{"issue":"3","key":"10.1002\/14651858.CD003456.pub2-BIB116|cit116","first-page":"255","article-title":"Nitric oxide in damage, disease and repair of the peripheral nervous system","volume":"51","author":"Zochodne","year":"2005","journal-title":"Cellular & Molecular Biology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003456.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003456.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:20:55Z","timestamp":1628529655000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003456.pub2"}},"subtitle":[],"editor":[{"given":"Alexander FJE","family":"Vrancken","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,4,19]]},"references-count":116,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003456.pub2","relation":{},"subject":[],"published":{"date-parts":[[2004,4,19]]}}}